Diabetic Retinopathy - Pathophysiology to Treatment: A Review

被引:2
|
作者
Singh, Randhir [1 ,2 ]
Walia, Aditya [3 ]
Kaur, Jasleen [3 ]
Kumar, Praveen [4 ]
Verma, Inderjeet [5 ]
Rani, Nidhi [3 ]
机构
[1] Cent Univ Punjab, Dept Pharmacol, Bathinda, Punjab, India
[2] Graph Era Hill Univ, Dept Pharm, Dehra Dun, India
[3] Chitkara Univ, Chitkara Coll Pharm, Chitkara, Punjab, India
[4] SunPharma, PO Barotiwala, Solan 174103, Himachal Prades, India
[5] Maharishi Markandeshwar Deemed Univ, MM Coll Pharm, Ambala, Haryana, India
关键词
Diabetic retinopathy; pathogenesis; microvascular changes; inflammation; diabetes; neurodegeneration; DEXAMETHASONE IMPLANT; OXIDATIVE STRESS; PERICYTE LOSS; IN-VITRO; RANIBIZUMAB; APOPTOSIS; ACTIVATION; RETINA; ANTIOXIDANT; CATARACT;
D O I
10.2174/0115733998259940231105200251
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic retinopathy (DR) is a microvascular disease affecting the eyes of diabetic patients, and is the most prevalent complication of diabetes mellitus. Vision improvement is not possible in the majority of DR patients. Several studies have indicated that microvascular changes, inflammation, oxidative stress, and retinal neurodegeneration are involved in the pathogenesis of DR. Therefore, there is an urgent need for the development of new and effective treatment for DR. Understanding the molecular mechanisms involved in the pathogenesis of disease will pave a way for better treatment and management of DR. This article has emphasized the molecular pathogenesis and treatment of DR.
引用
收藏
页码:58 / 67
页数:10
相关论文
共 50 条
  • [31] New approaches to the treatment of diabetic retinopathy
    Porta, M.
    Maldari, P.
    Mazzaglia, F.
    DIABETES OBESITY & METABOLISM, 2011, 13 (09) : 784 - 790
  • [32] Role of inflammatory cells in pathophysiology and management of diabetic retinopathy
    Kovoor, Elias
    Chauhan, Sunil K.
    Hajrasouliha, Amir
    SURVEY OF OPHTHALMOLOGY, 2022, 67 (06) : 1563 - 1573
  • [33] Pathophysiology of Diabetic Retinopathy: The Old and the New
    Kusuhara, Sentaro
    Fukushima, Yoko
    Ogura, Shuntaro
    Inoue, Naomi
    Uemura, Akiyoshi
    DIABETES & METABOLISM JOURNAL, 2018, 42 (05) : 364 - 376
  • [34] Pathophysiology and classification of diabetic retinopathy and maculopathy
    Lemmen, K. D.
    Bornfeld, N.
    DIABETOLOGE, 2008, 4 (02): : 93 - +
  • [35] Ubiquitin-proteasome system in diabetic retinopathy
    Svikle, Zane
    Peterfelde, Beate
    Sjakste, Nikolajs
    Baumane, Kristine
    Verkauskiene, Rasa
    Jeng, Chi-Juei
    Sokolovska, Jelizaveta
    PEERJ, 2022, 10
  • [36] Targeting pericyte retention in Diabetic Retinopathy: a review
    Bohler, Forrest
    Bohler, Lily
    Taranikanti, Varna
    ANNALS OF MEDICINE, 2024, 56 (01)
  • [37] Inflammation in diabetic retinopathy
    Tang, Johnny
    Kern, Timothy S.
    PROGRESS IN RETINAL AND EYE RESEARCH, 2011, 30 (05) : 343 - 358
  • [38] Review: Role of cAMP signaling in diabetic retinopathy
    Steinle, Jena J.
    MOLECULAR VISION, 2020, 26
  • [39] Pericyte Loss in Diabetic Retinopathy: Mechanisms and Consequences
    Beltramo, Elena
    Porta, Massimo
    CURRENT MEDICINAL CHEMISTRY, 2013, 20 (26) : 3218 - 3225
  • [40] Neurovascular Interaction and the Pathophysiology of Diabetic Retinopathy
    Qian, Haohua
    Ripps, Harris
    EXPERIMENTAL DIABETES RESEARCH, 2011,